Imaging was identified as one of the components that could play an important role in reducing the cost of clinical trials, which is a major component of drug approval costs. 尤其, using time-to-progression (often detected by imaging) rather than survival as the outcome measure can reduce costs and improve timeliness. Gen Consulting Company predicts the global clinical trial imaging market will grow from USD 1,176 百万 2022 兑美元 1,669 百万 2029, 实现复合年增长率 (复合年增长率) 的 5.2 百分.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global clinical trial imaging market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, 接下来是对服务的详细分析, 应用, 最终用户, 和地区. The global market for clinical trial imaging can be segmented by service: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, 其他的. The project and data management services segment held the largest share of the global clinical trial imaging market in 2022 预计在预测期内将持有其份额. Clinical trial imaging market is further segmented by application: cardiology, endocrinology, gastroenterology, 神经病学, 肿瘤学, 其他的. 全球范围, the oncology segment made up the largest share of the clinical trial imaging market. 基于最终用户, the clinical trial imaging market is segmented into: 学术界和研究机构, 合同研究组织 (合同研究组织), 医疗器械公司, 制药 & biotechnology companies, 其他的. The CROs segment was the largest contributor to the global clinical trial imaging market in 2022. 根据地区, the clinical trial imaging market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. North America is estimated to account for the largest share of the global clinical trial imaging market.

市场细分
按服务: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, 其他的
按申请: cardiology, endocrinology, gastroenterology, 神经病学, 肿瘤学, 其他的
按最终用户: 学术界和研究机构, 合同研究组织 (合同研究组织), 医疗器械公司, 制药 & biotechnology companies, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The global clinical trial imaging market report offers detailed information on several market vendors, including Biospective Inc., Biotelemetry Inc. (皇家飞利浦公司), Cardiovascular Imaging Technologies LLC (CVIT), ERT + Bioclinica, 公司. (Clario), ICON plc, Imaging Endpoints II LLC, Intrinsic Imaging LLC (WIRB – Copernicus Group, 公司), IXICO plc, Median Technologies S.A., Medical Metrics Inc. (康泰伦特, 公司), Medpace Holdings, 公司, Micron Inc., Parexel International Corporation, Perceptive Informatics, LLC D/B/A Calyx, pharmtrace klinische Entwicklung GmbH, Prism Clinical Imaging, 公司, ProScan Imaging LLC, Radiant Sage LLC, Resonance Health Ltd., WorldCare Clinical, 有限责任公司, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global clinical trial imaging market.
• To classify and forecast the global clinical trial imaging market based on service, 应用, 最终用户, 地区.
• To identify drivers and challenges for the global clinical trial imaging market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global clinical trial imaging market.
• To identify and analyze the profile of leading players operating in the global clinical trial imaging market.

为什么选择这份报告
• Gain a reliable outlook of the global clinical trial imaging market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.